Piperine–Chlorogenic Acid Hybrid Inhibits the Proliferation of the SK-MEL-147 Melanoma Cells by Modulating Mitotic Kinases
Piperine
Aurora kinase
PLK1
DOI:
10.3390/ph16020145
Publication Date:
2023-01-19T10:50:20Z
AUTHORS (11)
ABSTRACT
Melanoma is considered the most aggressive form of skin cancer, showing high metastatic potential and persistent mortality rates despite introduction immunotherapy targeted therapies. Thus, it important to identify new drug candidates for melanoma. The design hybrid molecules, with different pharmacophore fragments combined in same scaffold, an interesting strategy obtaining multi-target more effective anticancer drugs. We designed nine compounds bearing piperine chlorogenic acid pharmacophoric groups evaluated their antitumoral on melanoma cells distinct mutational profiles SK-MEL-147, CHL-1 WM1366. identified compound named PQM-277 (3a) be cytotoxic one, inhibiting mitosis progression promoting accumulation pro-metaphase metaphase by altering expression genes that govern G2/M transition onset. Compound 3a downregulated FOXM1, CCNB1, CDK1, AURKA, AURKB, PLK1, upregulated CDKN1A. Molecular docking showed could interact CUL1-RBX1 complex, which activity necessary trigger molecular events essential FOXM1 transactivation and, turn, gene expression. In addition, effectively induced apoptosis increasing BAX/BCL2 ratio. Our findings demonstrate antitumor candidate prototype support further investigations evaluate its treatment, especially refractory cases BRAF/MEK inhibitors.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (79)
CITATIONS (10)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....